192
Views
2
CrossRef citations to date
0
Altmetric
Original

Overview: Beyond guidelines and guidance—psychosocial perspectives on treatment interventions for young people with substance problems in the United Kingdom

Pages 203-224 | Published online: 10 Jul 2009

References

  • Advisory Council on the Misuse of Drugs (ACMD). Hidden harm: Responding to the needs of children of problem drug users. Home Office, London 2003
  • Beckett H, Heap J, McArdle P, Gilvarry E, Christian J, Bloor R, et al. Understanding problem drug use among young people accessing drug services: A multivariate approach using statistical modelling techniques. 2004, (Home Office Online Report 15/04) (Available at http://www.homeoffice.gov.uk/rds/pdfs04/rdsolr1504.pdf)
  • Bouza C, Magro A, Munoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence. Addiction 2004; 99: 811–828
  • Berglund M, Thelander S, Jonsson E. Treating alcohol and drug abuse: An evidence based review. Wiley-VCH, Weinheim 2003
  • Boys A, Farrell M, Taylor C, Marsden J, Goodman R, Brugha T, et al. Psychiatric morbidity and substance use in young people aged 13–15 years: Results from the Child and Adolescent Survey of Mental Health. British Journal of Psychiatry 2003; 182: 509–517
  • Brown SA. Measuring youth outcomes from alcohol and drug treatment. Addiction 2004; 99(Suppl. 2)38–46
  • Brown SA, D’Amico EJ, McCarthy DM, Tapert SF. Four year outcomes from adolescent alcohol and drug treatment. Journal of Studies on Alcohol 2001; 62: 381–388
  • Brown SA, Vik PW, Creamer VA. Characteristics of relapse following adolescent substance abuse treatment. Addictive Behaviors 1989; 14: 291–300
  • Burniston S, Dodd M, Elliott L, Orr L, Watson L. Drug treatment services for young people: A research review. Scottish Executive, Edinburgh 2000
  • Cabinet Office. Tackling drugs to build a better Britain: The government's 10-year strategy for tackling drug misuse. The Stationery Office, London 1998
  • Cabinet Office. Alcohol harm reduction strategy for England. Strategy Unit, London 2004
  • Carmen B, Angeles M, Munoz A, et al. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence. Addiction 2004; 99: 811–828
  • Catalano RF, Hawkins JD, Wells EA, Miller J, Brewer D. Evaluation of the effectiveness of adolescent drug abuse treatment. Journal of Studies on Alcohol 1990; 62: 381–388
  • Chung T, Maisto SA, Cornelius JR, Martin CS. Adolescents’ alcohol and drug use trajectories in the year following treatment. Journal of Studies on Alcohol 2004; 65: 105–114
  • Cornelius JR, Maisto SA, Martin CS, Bukstein OG, Salloum IM, Daley DC, et al. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addictive Behaviors 2004; 29: 1035–1038
  • Crisp AH, Gelder MG, Rix S, Meltzer HI, Rowlands OJ. Stigmatisation of people with mental illnesses. British Journal of Psychiatry 2000; 177: 4–7
  • Crome IB, Bloor R. Substance misuse and psychiatric comorbidity in adolescents. Current Opinion in Psychiatry 2005; 18: 435–439
  • Crome IB, Christian J, Green C. Tip of the national iceberg? Profile of adolescent patients prescribed methadone in an innovative community drug service. Drugs: Education, Prevention and Policy 1998; 5: 195–197
  • Crome IB, Christian J, Green C. The development of a unique adolescent community drug service: Education, prevention and policy implications. Drugs: Education, Prevention and Policy 2000; 7: 87–108
  • Crome IB, Ghodse A-H. Drug misuse in medical patients. Handbook of Liaison Psychiatry, G Lloyd, E Guthrie. Cambridge University Press, CambridgeUK, (In press)
  • Crome IB, Ghodse AH, Gilvarry E, McArdle P. Young people and substance misuse. Gaskell, London 2004a
  • Crome IB, McArdle P, Gilvarry E, Bailey S. Treatment. Young People and Substance Misuse, IB Crome, E Gilvarry, H Ghodse. Gaskell, London 2004b; 140–162
  • Crome IB, Shaikh N. Undergraduate medical education in substance misuse in Britain III: Can medical students drive change?. Drugs: Education, Prevention and Policy 2004; 11: 483–503
  • Cuijpers P, Riper H, Lemmers L. The effects on mortality of brief interventions for problem drinking: A meta-analysis. Addiction 2004; 99: 839–846
  • Currie SR, Clark S, Hodgkins DC, EI-Guebaly N. Randomised controlled trial of brief cognitive behavioural interventions for insomnia in recovering alcoholics. Addiction 2004; 99: 1121–1132
  • Dennis ML, Godley SH, Diamond G, Tims FM, Babor T, Donaldson J, et al. The Cannabis Youth Treatment (CYT) study: Main findings from two randomised trials. Journal of Substance Abuse Treatment 2004; 27: 197–213
  • Department of Health. Drug Misuse and Dependence: Guidelines on Clinical Management. Department of Health, London 1999
  • Department of Health. Young People's Substance Misuse Plans: DAT Guidance. Department of Health, London 2001
  • Department of Health. National Service Framework for Children, Young People and Maternity Services. Department of Health, London 2004
  • Doyle H, Delaney W, Tobin J. Follow-up study of young attenders at an alcohol unit. Addiction 1994; 89: 183–189
  • Edwards G, Guthrie S. A controlled trial of in-patient and out-patient treatment of alcohol dependence. Lancet 1967; 1: 555–559
  • Frisher M, Heatlie H, Hickman M. Estimating the prevalence of problematic and injecting drug use for Drug Action Team areas in England: A feasibility study using the Multiple Indicator Method. 2004, Home Office Online Report 34/04. (Available at http://www.homeoffice.gov.uk/rds/pdfs04/rdsolr3404.pdf)
  • Gilvarry E, Christian J, Johnson P, McArdle P, McCarthy S. Health Advisory Service 2000—Update on the HAS Report Substance of Young Needs (1996). Health Advisory Service, London 2001
  • Godfrey C, Stewart D, Gossop M. Economic analysis of costs and consequences of the treatment of drug misuse: 2-Year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction 2004; 99: 697–707
  • Gossop M, Marsden J, Stewart D, Kidd T. The National Treatment Outcome Research Study (NTORS): 4–5 Year follow-up results. Addiction 2003; 98: 291–303
  • Green AI, Tohen MF, Hamer RM, Strakowski SM, Leiberman JA, Glick I, et al. First episode schizophrenia-related psychosis and substance-use disorders: Acute response to olanzapine and haloperidol. Schizophrenia Research 2004; 66: 125–135
  • Health Advisory Service. The substance of young needs. The Stationery Office, London 1996
  • Henggeler S, Pickeral S, Brondino M. Multisystemic treatment of substance abusing and dependent delinquents: Outcomes, treatment fidelity and transportability. Mental Health Services Research 1999; 1: 171–184
  • Home Office. Statistics from the Regional Drug Misuse Databases for six months ending March 2001. Home Office, London 2002
  • Home Office. Provisional statistics from the national drug treatment monitoring system in England, 2001/02 and 2002/03. Home Office, London 2003
  • Hser YI, Grella CE, Hubbard RL, Hsieh SC, Fletcher BW, Brown BS, et al. An evaluation of drug treatments for adolescents in four US cities. Archives of General Psychiatry 2001; 58: 689–695
  • Jaycox LH, Morral AR, Juvonen J. Mental health and medical problems and service use among adolescent substance users. Journal of the American Academy of Child and Adolescent Psychiatry 2003; 42: 701–709
  • John U, Meyer C, Rumpf H-J, Hapke U. Smoking, nicotine dependence and psychiatric comorbidity—a population-based study including smoking cessation after three years. Drug and Alcohol Dependence 2004; 76: 287–295
  • Kaminer Y, Burleson JA. Psychotherapies for adolescent substance abusers: 15-Month follow-up. American Journal on Addictions 1999; 8: 114–119
  • Kelly TM, Cornelius JR, Clark DB. Psychiatric disorders and attempted suicide among adolescents with substance-use disorders. Drug and Alcohol Dependence 2004; 73: 87–97
  • Kirisci L, Tarter RE, Vanyukov M, Reynolds M, Habeych M. Relation between cognitive distortions and neurobehavior disinhibition on the development of substance use during adolescence and substance-use disorder by young adulthood: A prospective study. Drug and Alcohol Dependence 2004; 76: 125–133
  • Latimer WW, Newcomb M, Winters KC, Stinchfield RD. Adolescent substance abuse treatment outcome: The role of substance abuse problem severity, psychosocial, and treatment factors. Journal of Consulting and Clinical Psychology 2000; 68: 684–696
  • Liddle HA. Multidimensional family therapy for adolescent substance abuse: Findings from the Multidimensional Family Therapy research program. Problems of Drug Dependence 2001: Proceedings of the 63rd Annual Scientific Meeting (NIDA Research Monograph No. 182, pp. 113–115), LS Harris. National Institute on Drug Abuse, Bethesda, MD 2002
  • Liddle HA, Dakof GA, Parker K, Diamond GS, Barrett K, Tejeda M. Multidimensional family therapy for adolescent substance abuse: Results of a randomized clinical trial. American Journal of Drug and Alcohol Abuse 2001; 27: 651–687
  • Lingford-Hughes AR, Welch S, Nutt DJ. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 2004; 18: 293–335
  • Maisto SA, Chung TA, Cornelius JR, Martin CS. Factor structure of the SOCRATES in a clinical sample of adolescents. Psychology of Addictive Behaviours 2003; 17: 98–107
  • Maisto SA, Martin CS, Pollock NK, Cornelius JR, Chung TA. Non-problem drinking outcomes in adolescents treated for alcohol use disorders. Experimental and Clinical Psychopharmacology 2002; 10: 324–331
  • McLellan AT, Hagan TA, Levine M, Meyers K, Gould F, Bencivengo M, et al. Does clinical case management improve outpatient addiction treatment. Drug and Alcohol Dependence 1999; 55: 91–103
  • Miller WR, Wilbourne PL. Mesa Grande: A methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 2002; 97: 265–277
  • Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: A meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction 2002; 97: 279–292
  • Myers MG, Brown SA. The Adolescent Relapse Coping Questionnaire: Psychometric validation. Journal of Studies on Alcohol 1996; 57: 40–46
  • Myers MG, MacPherson L. Smoking cessation efforts among substance abusing adolescents. Drug and Alcohol Dependence 2004; 73: 209–213
  • New Zealand Health Technology Assessment (NZHTA). Adolescent therapeutic day programmes and community-based programmes for serious mental illness and serious drug and alcohol problems: A critical appraisal of the literature NZHTA Reprot No. 5. NZHTA, Christchurch, NZ 1998
  • Palomo T, Kostrzewa RM, Beninger RJ, Kostrzewa RM. Gene–environment interplay in alcoholism and other substance abuse disorders: Expressions of heritability and factors influencing vulnerabilities. Neurotoxicity Research 2004; 6: 343–361
  • Prochaska JO, DiClemente CC. The Transtheoretical Approach: Crossing the traditional boundaries of therapy. Dow Jones/Irwin, Homewood, IL 1984
  • Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Treatment main effects and matching effects on drinking during treatment. Journal of Studies on Alcohol 1998; 59: 631–639
  • Riggs PD, Hall SK, Mikulich-Gilbertson SK, Lohman M, Kayser A. A randomised controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2004; 43: 420–429
  • Rowe CL, Liddle HA, Greenbaum PE, Henderson CE. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. Journal of Substance Abuse Treatment 2004; 26: 129–140
  • Saitz R, Horton NJ, Larson MJ, Winter M, Samet JH. Primary medical care and reductions in addiction severity: A prospective cohort study. Addiction 2005; 100: 70–78
  • Shand F, Gates J, Fawcett J, Mattick R. The Treatment of Alcohol Problems: A Review of the Evidence. Department of Health and Ageing, Canberra, Australia: National Drug and Alcohol Research Centre 2003
  • Silberg J, Rutter M, D’Onofrio B, Eaves L. Genetic and environmental risk factors in adolescent substance use. Journal of Child Psychology and Psychiatry 2003; 44: 664–676
  • Slattery J, Chick J, Cochrane M, Craig J, Godfrey C, Kohli H, et al. Prevention of relapse in alcohol dependence. Health Technology Board for Scotland, Glasgow, UK 2003
  • Szapocznik J, Kurtines WM, Foote F, Perez-Vidal A, Hervis O. Conjoint versus one-person family therapy: Further evidence for the effectiveness of conducting family therapy through one person with drug-abusing adolescents. Journal of Consulting and Clinical Psychology 1986; 54: 395–397
  • Tait RJ, Hulse GK. A systematic review of the effectiveness of brief interventions with substance using adolescents by type of drug. Drug and Alcohol Review 2003; 22: 337–346
  • Thom B, Tellez C. A difficult business: Detecting and managing alcohol problems in general practice. British Journal of Addiction 1986; 81: 405–418
  • UKATT Research Team. United Kingdom Alcohol Treatment Trial (UKATT): Hypotheses, design and methods. Alcohol and Alcoholism 2001; 36: 11–21
  • Waldron HB, Kaminer Y. On the learning curve: The emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction 2004; 99: 93–105
  • Waldron HB, Slesnick N, Brody JL, Turner CW, Peterson TR. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. Journal of Consulting and Clinical Psychology 2001; 69: 802–813
  • Waldron HB, Turner CW, Ozechowski TJ. Trajectories of change in behavioural and family interventions for adolescent substance abuse and dependence. Treating Adolescent Substance Abuse: State of the Science, H Liddle, C Rowe. Cambridge University Press, New York 2004
  • White AM, Jordan JD, Schroeder KM, Acheson SK, Georgi BD, Sauls G. Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Substance Abuse 2004; 25: 53–59
  • Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Paediatrics 2003; 111: 179–185
  • Williams RJ, Chang SY. A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clinical Psychology: Science and Practice 2000; 7: 138–166
  • Wu P, Hoven CW, Fuller CJ. Factors associated with adolescents receiving drug treatment: Findings from the National Household Survey on Drug Abuse. The Journal of Behavioral Health Services and Research 2003; 30: 190–201

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.